SBE-β-CD CAS 182410-00-0 Betadex Sulfobutyl Etere Sodium Assay 95.0~105.0%
I-Ruifu Chemical ngumenzi ohamba phambili we-Betadex Sulfobutyl Ether Sodium (SBE-β-CD; Captisol) (CAS: 182410-00-0) kunye nomgangatho ophezulu.I-Ruifu inokubonelela ngenkonzo yehlabathi jikelele, ixabiso elikhuphisanayo, inkonzo egqwesileyo, amancinci kunye nezixa ezininzi ezikhoyo.Thenga iBetadex Sulfobutyl Ether Sodium,Please contact: alvin@ruifuchem.com
Igama leMchiza | Betadex Sulfobutyl Etere Sodium |
Izithethantonye | I-SBE-β-CD;I-SBE-beta-CD;Captisol;I-Sodium Sulfobutylether β-Cyclodextrin;I-Sodium Sulphobutylether-beta-Cyclodextrin;Sulfobutylether beta-Cyclodextrin;I-Beta-Cyclodextrin Sulfobutyl Ethers Iityuwa zeSodium;I-β-Cyclodextrin Sulfobutyl Ethers Iityuwa zeSodium |
Ubume beStokhwe | Kwi-Stock, iMveliso yoRhwebo |
Inombolo yeCAS | 182410-00-0 |
Ifomula yeemolekyuli | C42H70O35•xNa•x(C4H9O3S) |
Ubunzima beMolekyuli | (1134.99).x(22.99).x(137.17) g/mol |
Indawo yokunyibilika | 202.0~204.0℃(Disemba) |
Ukunyibilika | Inyibilika emanzini.I-insoluble kwi-acetone, i-Methanol, i-Chloroform |
Ikhowudi ye-HS | 3505100000 |
I-COA kunye ne-MSDS | Iyafumaneka |
Isampulu | Iyafumaneka |
Imvelaphi | Shanghai, China |
Uphawu | Ruifu Chemical |
Izinto | ImiGangatho yokuHlola | Iziphumo |
Imbonakalo | Umgubo oMhlophe ukuya kuMhlophe weAmorphous | Vumelana |
Ukuchongwa kwe-IR | Iibhendi zokufunxa ezifanayo njenge-USP Betadex Sulfobutyl Etere Sodium RS | Vumelana |
Ukuchongwa kwe-HPLC | Ixesha lokugcinwa kwencopho enkulu yesisombululo sesampuli sihambelana nesisombululo esiqhelekileyo | Vumelana |
I-Avareji yesiDanga soTshintsho | Vumelana | Vumelana |
I-Sodium yokuchonga | Chonga uvavanyo lunayo iSodium | Vumelana |
Isivavanyi | 95.0%~105.0% | 99.49% |
IBeta Cyclodextrin | ≤0.10% | Ayifunyanwa |
1,4-Butane Sultone | ≤0.5ppm | 0.19ppm |
I-Sodium chloride | ≤0.20% | 0.003% |
I-4-Hydroxybutane-1-Sulfonic Acid | ≤0.09% | Ayifunyanwa |
Bis(4-Sulfobtyl) Etere Disodium | ≤0.05% | Ayifunyanwa |
Iintsholongwane ze-Endotoxins | ≤20EU/g | <5EU/g |
Ubalo olupheleleyo lweAerobic Microbial | ≤100cfu/g | <10cfu/g |
Ukungunda okuDityanisiweyo kunye namagwele kubalwa | ≤50cfu/g | <10cfu/g |
Escherichia Coli | Ukungabikho | Ayifunyanwa |
Ukucaca kwesisombululo | Isisombululo se-30% (w/v) sicacile kwaye ngokusisiseko asinamasuntswana ezinto zangaphandle. | Vumelana |
I-Avareji yesiDanga soTshintsho | 6.2~6.9 | 6.5 |
Incopho I | 0.0~0.3 | 0 |
Incopho II | 0.0~0.9 | 0.62 |
Incopho III | 0.5~5.0 | 1.41 |
Incopho IV | 2.0~10.0 | 4.46 |
Incopho V | 10.0~20.0 | 11.72 |
Incopho VI | 15.0 ~ 25.0 | 20.75 |
Incopho VII | 20.0~30.0 | 29.04 |
Incopho VIII | 10.0~25.0 | 21.59 |
PeakI X | 2.0~12.0 | 7.83 |
Incopho X | 0.0~4.0 | 2.57 |
pH | 4.0~6.8 | 4.8 |
Isiqulatho samanzi | ≤10.0% | 4.9% |
I-Infrared Spectrum | Iyahambelana neSakhiwo | Iyahambelana |
Ukuqukumbela | Le mveliso ngokuhlolwa ihambelana nomgangatho we-USP35 |
Umqulu:Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Londoloza kwizikhongozeli ezivalwe kakuhle kwaye uzigcine kwindawo epholileyo, eyomileyo (2~8℃) kunye nendawo yokugcina impahla enomoya owaneleyo kude nezinto ezingahambelaniyo.Khusela ukukhanya kunye nokufuma.
Ukuhambisa ngenqanawe:Zisa kwihlabathi liphela ngomoya, ngeFedEx / DHL Express.Ukubonelela ngokukhawuleza nangokuthembekileyo.
Betadex Sulfobutyl Etere Sodium
C42H70−nO35 · (C4H8SO3Na)n 2163 xa n = 6.5
I-Beta cyclodextrin sulfobutyl ethers, iityuwa zesodium;
I-Beta cyclodextrin sulfobutyl ether sodium [182410-00-0].
INGCACISO
I-Betadex Sulfobutyl Ether Sodium ilungiswe yi-alkylation ye-betadex usebenzisa i-1,4-butane sultone phantsi kweemeko ezisisiseko.
Umndilili weqondo lotshintsho kwi-betadex yi-NLT 6.2 kunye ne-NMT 6.9.
Iqulethe i-NLT 95.0% kunye ne-NMT 105.0% ye-C42H70−nO35 · (C4H8SO3Na)n (n = 6.2–6.9), ibalwa ngokwesiseko se-anhydrous.
UKUCHAZA
• A. UKUFUNWA KWE-IFRARED <197K>
• B. Ixesha lokugcinwa kwencopho enkulu yeSampuli yesisombululo ihambelana nesisombululo esisemgangathweni, njengoko sifunyenwe kwi-Assay.
• C. Iyazifezekisa iimfuno zovavanyo lwe-Average Degree of Substitution.
• D. IIMVAVANYO ZOKUCHAZA NGOKUBANZI, iSodium 〈191〉
UVAVANYO
• INKQUBO
Isigaba seselula: 0.1 M potassium nitrate kumxube we-acetonitrile kunye namanzi (1: 4)
Isisombululo esisemgangathweni: 10 mg / mL ye-USP Betadex Sulfobutyl Ether Sodium RS kwisigaba seMobile
Isisombululo sesampuli: 10 mg / mL ye-Betadex Sulfobutyl Ether Sodium kwisigaba seMobile
Inkqubo yeChromatographic
(Jonga iChromatography <621>, Ukufaneleka kweNkqubo.)
Indlela: LC
Umtshina: Isalathiso sokuqhafaza
Ubushushu be-detector: 35 ± 2 °
Ikholomu: 7.8-mm × 30-cm ikholamu yokuhlalutya;ukupakisha i-L37.[QAPHELA-Hlala ikholamu ngesisombululo se-acetonitrile kunye namanzi (1: 9) ekugqityweni koluhlu lokuqhuba.]
Izinga lokuhamba: 1.0 mL / min
Ubungakanani betofu: 20 µL
Ukufaneleka kwenkqubo .
Isampulu: Isisombululo esisemgangathweni
Iimfuno zokufaneleka
Ukutenxa komgangatho ozalanayo: NMT 2.0%
Uhlalutyo
Iisampulu: Isisombululo esisemgangathweni kunye nesisombululo seSampuli
Bala ipesenti ye-betadex sulfobutyl ether sodium [C42H70−nO35 · (C4H8SO3Na)n] kwisahlulo seBetadex Sulfobutyl Ether Sodium ethathiweyo:
Isiphumo = (rU/rS) × (CS/CU) × 100
rU = impendulo ephezulu ye-betadex sulfobutyl ether
sodium evela kwiSampuli isisombululo
rS = impendulo ephezulu ye-betadex sulfobutyl ether
sodium ukusuka kwisisombululo esiPhakathi
CS = ukuxinwa kwe-USP Betadex Sulfobutyl Ether
Isodium RS kuMgangatho wesisombululo (mg/mL)
I-CU = i-concentration ye-Betadex Sulfobutyl Ether Sodium kwi-Sample solution (mg / mL)
Indlela yokwamkela: 95.0% ~ 105.0% kwisiseko se-anhydrous
UBUNGCOLA
• IIMETALI EZINZIMA, Indlela II <231>: NMT 5 ppm
• UMDA WE-BETA CYCLODEXTRIN (BETADEX)
Isisombululo A: 25 mM sodium hydroxide
Isisombululo B: 250 mM sodium hydroxide kunye ne-1 M potassium nitrate
Isigaba esiphathwayo: Jonga iTheyibhile 1.
Uluhlu loku-1
Ixesha (min) | Isisombululo A (%) | Isisombululo B (%) |
0 | 100 | 0 |
4 | 100 | 0 |
5 | 0 | 100 |
10 | 0 | 100 |
11 | 100 | 0 |
20 | 100 | 0 |
Isisombululo esisemgangathweni: 2 µg/mL ye-USP Beta Cyclodextrin RS
Isisombululo sesampuli: 2 mg / mL ye-Betadex Sulfobutyl Ether Sodium
Inkqubo yeChromatographic
(Jonga i-Chromatography <621>, Ukufaneleka kweNkqubo kunye ne-Ion Chromatography <1065>.)
Indlela: IC
Umtshina: I-amperometry ephuhlisiweyo (iseli ye-amperometric ene-electrode esebenzayo yegolide kunye ne-electrode yereferensi yesilivere)
Umqolo
Umlindi: 4.0-mm × 5-cm anion-exchange;ukupakisha i-L61
Uhlalutyo: 4.0-mm × 25-cm anion-exchange;
ukupakisha i-L61
Ubushushu bekholamu: 50 ± 2 °
Izinga lokuhamba: 1.0 mL / min
Ubungakanani betofu: 20 µL
I-Waveform ye-pulsed amperometric detector: Jonga iTheyibhile yesi-2.
Uluhlu lwesi-2
Ixesha (ama) | Umbane (V) |
0.00 | 0.10 |
0.30 | Qala ukudibanisa |
0.50 | 0.10 |
0.50 | Yeka ukudibanisa |
0.51 | 0.60 |
0.60 | -0.60 |
0.65 | -0.60 |
Ukufaneleka kwenkqubo
Isampulu: Isisombululo esisemgangathweni
Iimfuno zokufaneleka
Ukutenxa umgangatho ozalanayo: NMT 5.0%
Uhlalutyo
Iisampulu: Isisombululo esisemgangathweni kunye nesisombululo seSampuli
Bala ipesenti ye-beta cyclodextrin (betadex) kwinxalenye yeBetadex Sulfobutyl Ether Sodium ethathiweyo:
Isiphumo = (rU/rS) × (CS/CU) × F × 100
rU = impendulo ephezulu ye-beta cyclodextrin kwisisombululo seSampuli
rS = impendulo ephezulu ye-beta cyclodextrin ukusuka kwisisombululo esiPhakathi
CS = ukuxinwa kwe-USP Beta Cyclodextrin RS kwisisombululo esiPhakathi (µg/mL)
I-CU = i-concentration ye-Betadex Sulfobutyl Ether Sodium kwi-Sample solution (mg / mL)
F = into yokuguqula (10-3 mg/µg)
Indlela yokwamkelwa: NMT 0.1%
• UMDA WE-1,4-BUTANE SULTONE
Isisombululo somgangatho wangaphakathi: 0.25 µg/mL ye-diethyl sulfone
Isisombululo sesitokhwe esisemgangathweni A: 0.5 µg/mL ye-1,4-butane sultone
Isisombululo sesitokhwe esisemgangathweni B: 1.0 µg/mL ye-1,4-butane sultone
Isisombululo sesitokhwe esisemgangathweni C: 2.0 µg/mL ye-1,4-butane sultone
Isisombululo sesitokhwe sesampuli: 250 mg / mL yeBetadex Sulfobutyl Ether Sodium kwisisombululo esisemgangathweni sangaphakathi
Isisombululo esingenanto, kunye nezisombululo zeSampuli A, B, C, kunye no-D:
Landela iThebhile 3 ukubeka ubuninzi besisombululo somgangatho wangaphakathi, isisombululo ngasinye sesitokhwe esisemgangathweni, isisombululo sesitokhwe seSampule, amanzi, okanye i-methylene chloride kwityhubhu yovavanyo lweglasi nganye ene-stopper.[QAPHELA-I-screw-capped, ityhubhu yokuvavanya i-10-mL ifanelekile.] Hlanganisa kwi-vortex mixer ityhubhu nganye yokuvavanya i-30 s, kwaye uvumele ukuba ime ubuncinane imizuzu emi-5 okanye kude kube nokuhlukana okupheleleyo kwesigaba.Khipha isigaba se-organic kwi-vial ye-GC kunye netywina.[QAPHELA-Ngononophelo olukhulu thatha ubuncinci obunokwenzeka besigaba se-aqueous.] Izixa ezongeziweyo ze-1,4-butane sultone kwi-Sample solutions A, B, C, and D are 0.5, 1.0, 2.0, and 0 µg, ngokulandelanayo.
Itheyibhile 3
Igama leSampule | Isisombululo 1 Songeziwe (mL) | Isisombululo 2 Songeziwe (mL) | I-Methylene Chloride Yongeziwe (mL) |
Isisombululo esingenanto | Isisombululo somgangatho wangaphakathi, 4.0 | Amanzi, 1.0 | 1.0 |
Isampuli yesisombululo A | Isampuli yesisombululo sesitokhwe, 4.0 | Isisombululo sesitokhwe esisemgangathweni A, 1.0 | 1.0 |
Isampuli yesisombululo B | Isampuli yesisombululo sesitokhwe, 4.0 | Isisombululo sesitokhwe esisemgangathweni B, 1.0 | 1.0 |
Isampuli yesisombululo C | Isampuli yesisombululo sesitokhwe, 4.0 | Isisombululo sesitokhwe esisemgangathweni C, 1.0 | 1.0 |
Isampuli yesisombululo D | Isampuli yesisombululo sesitokhwe, 4.0 | Amanzi, 1.0 | 1.0 |
[QAPHELA-Lungisa ngokukhawuleza phambi kokusetyenziswa.]
Inkqubo yeChromatographic
(Jonga iChromatography <621>, Ukufaneleka kweNkqubo.)
Indlela: GC
Umtshina: Iionization yomlilo
Ikholamu: 0.32-mm × 25-m fused-silica ikholamu capillary;0.5-µm umaleko wesigaba G46
Ubushushu
Umtshina: 270 °
I-port yokutofa: 200 °
Uluhlu: Bona inkqubo yobushushu kwiTheyibhile 4
Uluhlu lwesi-4
Iqondo lobushushu lokuqala (°) Irempu yoBubushushu (°/min) Iqondo lobushushu lokuGqibela (°) Ukubamba ixesha kuBubushushu bokugqibela (umzuzu)
100 10 200 -
200 35 270 5
Irhasi yeCarrier: Helium, ngokuqhelekileyo kwi-12 psi inlet yoxinzelelo
Ubungakanani bokutofa: 1.0 µL
Uhlobo lwe-injection: I-injection ye-splitless ye-0.5 min, ize yahlulwe kwi-50 mL / min.[QAPHELA-Ukusetyenziswa kwesitofu esifanelekileyo esingacalulwanga kuyacetyiswa.]
Ukufaneleka kwenkqubo
Isampulu: Isampuli yesisombululo B
[QAPHELA-Amaxesha anxulumeneyo okugcina i-diethyl sulfone kunye ne-1,4-butane sultone yi-0.7 kunye ne-1.0, ngokulandelelanayo.]
Iimfuno zokufaneleka
Ukutenxa umgangatho ozalanayo: NMT 10.0%
Uhlalutyo
Iisampulu: Isisombululo esingenanto, izisombululo zesampulu A, B, C, kunye noD
Lungisa umlinganiselo weempendulo eziphezulu ze-1,4-butane sultone kwi-diethyl sulfone kwiSampuli isisombululo A, B, C, okanye D ngokukhupha umlinganiselo weempendulo eziphezulu ze-1,4-butane sultone kwi-ethyl sulfone kwisisombululo esingenanto. .Cwangcisa umlinganiselo ochanekileyo wepeak impendulo ye-1,4-butane sultone ukuya kwincopho yempendulo ye-diethyl sulfone kwiSampule yesisombululo A, B, C okanye D, xa kuthelekiswa nobuninzi obudityanisiweyo, kwi-µg, ye-1,4-butane sultone.Yongeza umgca odibanisa amanqaku kwigrafu de udibane ne-axis yobungakanani.Umgama phakathi kwale ndawo kunye nokuhlangana kwee-axes umele ubuninzi be-1,4-butane sultone, A, kwiµg, kwisahlulo se-4-mL seSampule yesisombululo sesitokhwe.Bala umxholo we-1,4-butane sultone kwisahlulo se-Betadex Sulfobutyl Ether Sodium ethathiweyo:
Isiphumo = A/(VExt × CU × F)
A = imiselwe ngasentla
I-VExt = umthamo weSampuli yesisombululo sesitokhwe esisetyenziswe kwisinyathelo sokukhutshwa, i-4.0 mL
I-CU = i-concentration ye-Betadex Sulfobutyl Ether Sodium kwi-Sample stock solution (mg / mL)
F = into yokuguqula (10-3 g/mg)
Indlela yokwamkela: i-hydroxybutane-1-sulfonic acid, okanye i-NMT 0.5 ppm
• UMDA WESODIUM CHLORIDE, 4-HYDROXYBUTANE-1-SULFONIC ACID, KUNYE NE-BIS(4-SULFOBUTYL) ETHI I-DISODIUM
Isisombululo A: I-5 mM i-sodium hydroxide, i-degas kwisitya esivaliweyo se-15 min
Isisombululo B: I-25 mM i-sodium hydroxide, i-degas kwisitya esivaliweyo se-15 min
Isigaba esiphathwayo: Jonga iTheyibhile 5
Uluhlu 5
Ixesha (min) | Isisombululo A (%) | Isisombululo B(%) |
0 | 100 | 0 |
4 | 100 | 0 |
10 | 70 | 30 |
24 | 70 | 30 |
25 | 100 | 0 |
40 | 100 | 0 |
Isisombululo sokuhlamba ikholomu A: 50 mM sodium citrate
Isisombululo sokuhlamba ikholomu B: 150 mM sodium hydroxide
Isisombululo esisemgangathweni: Lungiselela isisombululo esinogxininiso olwaziwayo lwe-8 µg/mL ye-USP ye-Sodium Chloride RS, i-4µg/mL ye-4-hydroxybutane-1-sulfonic acid, kunye ne-4 µg/mL ye-bis (4-sulfobutyl) ether disodium.
Isisombululo sesampuli: 4 mg / mL ye-Betadex Sulfobutyl Ether Sodium
Inkqubo yeChromatographic
(Jonga i-Chromatography <621>, Ukufaneleka kweNkqubo kunye ne-Ion Chromatography <1065>.)
Indlela: IC
Umtshina: Ukuqhuba
Uluhlu: 30 µS
Okwangoku: 100 mA
Ikholomu: [QAPHELA-Ekupheleni kokubaleka ngalunye, coca ikholamu usebenzisa isisombululo sokuhlamba iKholamu A ngesantya sokuhamba kwe-1 mL/min ye-35 min emva koko usebenzisa iKholamu yokuhlamba isisombululo B kwisantya esifanayo sokuhamba kwe-35 min.]
Umlindi: 4.0-mm × 5.0-cm anion-exchange;ukupakisha i-L61
Uhlalutyo: 4.0-mm × 25-cm anion-exchange;ukupakisha i-L61
Ubushushu bekholamu: 30 °
Umcinezeli: I-Micromembrane anion autosuppressor1 okanye inkqubo efanelekileyo yokunciphisa imichiza
Ukucinezela: Ukunyanzeliswa ngokuzenzekelayo
Izinga lokuhamba: 1.0 mL / min
Ubungakanani betofu: 20 µL
Ukufaneleka kwenkqubo
Isampulu: Isisombululo esisemgangathweni
[QAPHELA-Amaxesha okugcina anxulumeneyo anikezelwe ngolwazi kuphela.Amaxesha okugcina anxulumene ne-4-hydroxybutane-1-sulfonate ion, ion chloride, kunye ne-bis(sulfobutyl) ether ion yi-1.0, 1.4, kunye ne-8.6, ngokulandelanayo.]
Iimfuno zokufaneleka
Isisombululo: NLT 2.0
Ukutenxa umgangatho ozalanayo: NMT 10.0%
Uhlalutyo
Iisampulu: Isisombululo esisemgangathweni kunye nesisombululo seSampuli
Bala ipesenti ye-sodium chloride, i-4-hydroxybutane-1-sulfonic acid, okanye i-bis (sulfobutyl) i-ether disodium kwisahlulo se-Betadex Sulfobutyl Ether Sodium ethathiweyo:
Isiphumo = (rU/rS) × (CS/CU) × F × 100
i-rU = impendulo ephezulu ye-sodium chloride, i-4-hydroxybutane-1-sulfonic acid, okanye i-bis (sulfobutyl) i-ether disodium evela kwiSample isisombululo
rS = impendulo ephezulu ye-sodium chloride, i-4-hydroxybutane-1-sulfonic acid, okanye i-bis (sulfobutyl) i-ether disodium evela kwisisombululo esiPhakathi
I-CS = i-concentration ye-sodium chloride, i-4-hydroxybutane-1-sulfonic acid, okanye i-bis (sulfobutyl) i-ether disodium kwisisombululo soMgangatho (µg / mL)
I-CU = i-concentration ye-Betadex Sulfobutyl Ether Sodium kwi-Sample solution (mg / mL)
F = into yokuguqula (10−3 0 100 0 mg/µg)
Iinqobo zokwamkelwa
Isodium chloride: NMT 0.2%
4-Hydroxybutane-1-sulfonic acid: NMT 0.09%
I-Bis(sulfobutyl) ether disodium: NMT 0.05%
IIMVAVANYO EZITHILE
UVAVANYO lwe-ENDOTOXINS YE-BACTERIAL <85>: Inqanaba leendotoxins zebhaktheriya linjalo ukuba imfuno phantsi kwefom ye-dosage echaphazelekayo i-monograph (s) apho i-Betadex Sulfobutyl Ether Sodium isetyenziselwa khona.Apho ilebula ichaza ukuba i-Betadex Sulfobutyl Ether Sodium kufuneka ixhomekeke ekuqhubekeni phambili ngexesha lokulungiswa kweefom ze-dosage ye-injection, inqanaba le-endotoxins yebhaktheriya kukuba imfuno phantsi kwefom ye-dosage efanelekileyo i-monograph (s) apho i-Betadex Sulfobutyl Ether Sodium isetyenziswa. inokuhlangatyezwana nayo.
• UVAVANYO LWEMICROBIAL ENUMERATION <61> kunye noVAVANYO LWEMICROORGANISMS ESHICILEYO <62>: Itotali ye-aerobic microbial count ayigqithi kwi-100 cfu/g, kwaye inani elidityanisiweyo lokungunda kunye negwele alidluli kwi-50 cfu/g.Ihlangabezana neemfuno zovavanyo lokungabikho kwe-Escherichia coli.
• UKUCACA NGESONDLULO
Isisombululo sesampuli: 30% (w/v) isisombululo
Uhlalutyo: Phonononga isisombululo seSampuli usebenzisa ibhokisi yokukhanya ngokuchasene nemvelaphi emhlophe nemnyama, kwaye urekhode ubukho bayo nayiphi na inkungu, i-fluorescence, iifayibha, amachaphaza, okanye enye into yangaphandle.
Iinqobo zokwamkelwa: Isisombululo sicacile, kwaye ngokusisiseko sikhululekile kumasuntswana omcimbi wangaphandle.
• I-Avareji yedigri yokutshintshwa
Qhuba i-electrolyte: 30 mM benzoic acid kwaye ilungelelaniswe kwi-pH elungele isixhobo esisetyenziswe ngokudityaniswa kwe-100 mM tris(hydroxymethyl) aminomethane buffer.
[QAPHELA-Ngenxa yokwahluka phakathi kwee-capillaries, i-electrolyte enye esebenza kwihlabathi jikelele pH ayichazwanga.
Endaweni yoko, eyona pH edityaniswe necapillary nganye kufuneka imiselwe ngokwesixhobo sokufundisa.]
Isisombululo esisemgangathweni: 10 mg / mL ye-USP Betadex Sulfobutyl Ether Sodium RS
Isisombululo sesampuli: 10 mg / mL ye-Betadex Sulfobutyl Ether Sodium
Inkqubo yokuhlanjululwa kweCapillary: Sebenzisa iibhotile ze-electrolyte eziqhutywa ngokwahlukeneyo zokuhlanjululwa kwe-capillary kunye nohlalutyo lwesampulu.Yenza ukuhlalutya kwangaphambili ukuhlalutya imihla ngemihla ngaphambi kokuhlalutya ngalunye: hlambulula i-capillary nge-0.1 N sodium hydroxide kwi-30 min, ngamanzi e-NLT 2 h, kunye ne-Run electrolyte ye-NLT 1 h.Yenza i-rinses pre-injection phambi kwenaliti nganye ngolu hlobo lulandelayo.Hlanza i-capillary nge-0.1 N sodium hydroxide ye-NLT 1 min, kunye ne-Run electrolyte ye-NLT 3 min.Ukuba i-capillary entsha isetyenzisiweyo, ngaphezu kweerinses eziqhelekileyo ezichazwe ngasentla, i-capillary entsha idinga ukuhlanjululwa ngaphambi kokusetyenziswa kwayo kokuqala.Hlanza i-capillary entsha nge-1 M ye-sodium hydroxide kwi-1 h, ilandelwe yi-2-h yokuhlanjululwa kwamanzi.
Inkqubo ye-Electrophoretic
(Jonga iCapillary Electrophoresis <1053>.)
Imowudi: Ukusebenza okuphezulu kweCE
I-Detector: I-Inverse UV 200 nm, kunye ne-bandwidth ye-20nm.[QAPHELA-Ubude bobude be-205 nm kunye ne-bandwidth ye-10nm ingasetyenziswa njengenye indlela.]
Ikholamu: IiNcopho zeSodium I–X (% Indawo eNcopho) 50-µm × 50-cm ikholamu yesilica edityanisiweyo
Ubushushu bekholamu: 25 °
Umbane osetyenziswayo: 0.00 ukuya +30.00 kV umgca werempu ngaphezulu kwe-10 min, emva koko ube yi-30 kV enye imizuzu engama-20
Ubungakanani be-injection: Imiqulu elinganayo kwi-0.5 psi kwi-10 s
Ukufaneleka kwenkqubo
Isampulu: Isisombululo esisemgangathweni
[QAPHELA-Jonga iThebhile 6 malunga namaxesha asondeleneyo okufuduka kwe-betadex sulfobutyl ether sodium peaks I-X (betadex sulfobutyl ether sodium peaks I, II, III, ..., X, iqulethe i-molecule ye-beta cyclodextrin ene-1, 2, 3, ..., 10 sulfobutyl substituent(s), ngokulandelelanayo).Amaxesha okufuduka ahambelanayo ngawenjongo yolwazi kuphela ukunceda ekuchongweni kwencopho.]
Uluhlu 6
Betadex Sulfobutyl Etere Incopho yeSodium I–X | Ixesha lokuFuduka elizalanayo |
I | 0.58 |
II | 0.63 |
III | 0.69 |
IV | 0.77 |
V | 0.83 |
VI | 0.91 |
VII | 1.00 |
VIII | 1.10 |
IX | 1.20 |
X | 1.30 |
Iimfuno zokufaneleka
Isisombululo: NLT 0.9, phakathi kwe-betadex sulfobuty ether sodium peak IX kunye ne-betadex sulfobutyl ether yesodium peak X
Uhlalutyo
Iisampulu: Sebenzisa i-electrolyte, amanzi, isisombululo esiPhakathi, kunye nesisombululo seSampuli
Ijova isisombululo soMgangatho kunye nesisombululo seSampuli ngokusebenzisa uxinzelelo oluhlukeneyo lwe-0.5 psi, elilingana ne-34 mbar, kwi-10 s, ilandelwa yi-injection ye-Run electrolyte kwi-0.5 psi kwi-2 s.[QAPHELA-Inaliti zoxinzelelo kufuneka zenziwe ngevial yamanzi okanye Qalisa i-electrolyte ekupheleni kwecapillary.]
Rekhoda i-electropherograms, kwaye ulinganise iimpendulo eziphezulu ze-betadex sulfobutyl ether sodium peaks (I ukuya ku-X).Bala indawo eyincopho echanekileyo, i-AI, kwincopho nganye kwi-eletropherogram:
Indawo eNcopho eLungileyo A = Indawo eNcopho x Ubude beCapillary obusebenzayo (cm) / Ixesha lokufuduka
Lungiselela iindawo ezizincopho ezilungisiweyo ngokubonisa nganye njengepesenti yommandla wemvulophu ochanekileyo olungisiweyo:
Ummandla oNomaza, NA: A / n∑i=1 Ai x 100
n = inqanaba eliphezulu lokutshintsha
Qinisekisa iqondo eliphakathi lokutshintsha:
I-Avareji yesiDanga soTshintsho = n∑i=1 (Inqanaba lokuTshintshwa kweNcopho x NA) / 100
Iikhrayitheriya zokwamkelwa: 6.2 ~ 6.9 kwiqondo eliphakathi lokutshintshwa
Ngomnye we-betadex sulfobutyl ether sodium peaks I-X, jonga umda womda (% indawo ephezulu) kwiThebhile 7.
Uluhlu 7
Betadex Sulfobutyl Etere Incopho yeSodium I–X | Uluhlu loMda (% Ummandla oPhakamileyo) |
I | 0-0.3 |
II | 0-0.9 |
III | 0.5-5.0 |
IV | 2.0-10.0 |
V | 10.0-20.0 |
VI | 15.0-25.0 |
VII | 20.0-30.0 |
VIII | 10.0-25.0 |
IX | 2.0-12.0 |
X | 0-4.0 |
• PH <791>: 4.0-6.8, kwisisombululo se-30% (w/v) kwi-carbon dioxide-free water
• UKUMISELWA KWAMANZI, Indlela I <921>: NMT 10.0%
IIMFUNO EZONGEZELELWEYO
• UKUPAKISHWA NOKUGCINA: Zigcine kwizikhongozeli ezivaliweyo, uze uzigcine kwindawo yobushushu begumbi.Khusela ukufuma.
• UKULEBHULA: Ileyibhelishe ukubonisa ukusetyenziswa kwayo xa kusenziwa iifomu zethamo elitofwayo.
• IMIGANGATHO YE-USP REFERENCE <11>
USP Beta Cyclodextrin RS
USP Betadex Sulfobutyl Etere Sodium RS
USP Endotoxin RS
USP Sodium Chloride RS■1S (NF30)
Ukuthenga njani?Nceda uqhagamshelaneDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Amava Eminyaka Eli-15?Sineminyaka engaphezu kwe-15 yamava ekwenziweni nasekuthumeleni kumazwe angaphandle uluhlu olubanzi oluphezulu lwamayeza aphakathi okanye amachiza alungileyo.
Iimarike eziphambili?Thengisa kwimarike yasekhaya, eMntla Melika, eYurophu, eIndiya, eKorea, eJapan, eOstreliya, njl.
Iingenelo?Umgangatho ophezulu, ixabiso elifikelelekayo, iinkonzo zengcali kunye nenkxaso yobugcisa, ukuhanjiswa ngokukhawuleza.
UmgangathoIsiqinisekiso?Inkqubo yokulawula umgangatho ongqongqo.Izixhobo zobuchwephesha zokuhlalutya ziquka i-NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, njl.
Iisampulu?Uninzi lweemveliso zibonelela ngeesampulu zasimahla zokuvavanya umgangatho, iindleko zokuthumela kufuneka zihlawulwe ngabathengi.
Factory Audit?Uphicotho-zincwadi lwasefektri wamkelekile.Nceda wenze idinga kwangaphambili.
MOQ?Akukho MOQ.Umyalelo omncinci wamkelekile.
Ixesha lokuzisa? Ukuba ngaphakathi kwesitokhwe, ukuhanjiswa kweentsuku ezintathu kuqinisekisiwe.
Ezothutho?Nge-Express (FedEx, DHL), ngoMoya, ngoLwandle.
Amaxwebhu?Emva kwenkonzo yokuthengisa: I-COA, i-MOA, i-ROS, i-MSDS, njl.
Udibaniso lweSiko?Inokubonelela ngeenkonzo zesiko lokudibanisa ukuze zilungele iimfuno zakho zophando.
Immimiselo yokuhlawula?I-invoyisi yeProforma iya kuthunyelwa kuqala emva kokuqinisekiswa kwe-odolo, efakwe kwiinkcukacha zethu zebhanki.Intlawulo nge-T / T (i-Telex Transfer), i-PayPal, i-Western Union, njl.
I-Betadex Sulfobutyl Ether Sodium (i-SBE-β-CD; i-Captisol) (i-CAS: i-182410-00-0) luhlobo olutsha lwe-cyclodextrin eguqulwa ngamakhemikhali kunye nesakhiwo esenzelwe ukulungelelanisa ukunyibilika kunye nokuzinza kwamachiza.
I-Betadex Sulfobutyl Etere Sodium luhlobo olutsha lwe-excipient yokulungiselela amayeza, eye-sulfonic acid derivative ye-anionic enyibilikayo kakhulu emanzini cyclodextrin.Inokuthi idityaniswe kakuhle kunye neemolekyuli zamachiza ukuba zenze ii-non-covalent complexes, eziphucula ukuzinza, ukunyibilika kwamanzi, kunye nokhuseleko lwechiza, kunye nokuphucula ngokufanelekileyo umsebenzi we-biological we-molecule yeziyobisi.I-nephrotoxicity yayo incinci, kwaye inokunciphisa i-hemolysis yeziyobisi., Lawula izinga lokukhutshwa kwechiza.
I-Betadex Sulfobutyl Ether Sodium inokwenza ii-complexes ezingenayo i-noncovalent kunye neentlobo ezininzi zeekhompawundi ezibandakanya iimolekyuli ezincinci ze-organic, i-peptides, kunye neeprotheni.Kwakhona kunokwandisa ukunyibilika kwazo kunye nokuzinza emanzini.Ukusetyenziswa kokuqala kwe-sulfobutylether bcyclodextrin kwakumalungiselelo okujova;Inokusetyenziswa kwakhona kwiifom zedosi yomlomo eqinileyo kunye neyolwelo, kunye ne-ophthalmic, i-inhalation, kunye ne-intranasal formulations.I-Betadex Sulfobutyl Ether Sodium inokusebenza njenge-agent ye-osmotic kunye / okanye i-solubilizer yokuhanjiswa okulawulwayo, kwaye ineempawu zokukhusela i-antimicrobial xa zikhona kwiindawo ezaneleyo.Ubungakanani be-Betadex Sulfobutyl Ether Sodium enokuthi isetyenziswe ixhomekeke kwinjongo yokufakwa ekuqulunqweni, indlela yokulawula, kunye nokukwazi kwe-cyclodextrin ukuya kwi-complex kunye neyeza elihanjiswayo.
I-Betadex Sulfobutyl Ether Sodium ithathwe kwi-b-cyclodextrin, eyi-nephrotoxic xa ilawulwa ngumzali.Nangona kunjalo, uphando luye lwabonisa ukuba i-sulfobutylether bcyclodextrin inyamezeleke kakuhle kwiidosi eziphezulu, xa ilawulwa nge-intravenous bolus injections, ngomlomo, kunye ne-inhalation.Ukuya kuthi ga kwi-9 g/ngosuku inokulawulwa ngokufakwa kwe-IV kwi-voriconazole formulation enelayisensi.Ukhuseleko olulandela iidosi eziphezulu ze-sulfobutylether β-cyclodextrin ulawulo lwe-intravenous ebantwini luhlala luphandwa.I-Betadex Sulfobutyl Ether Sodium iphantsi kwebhetri ebanzi ye-in vitro kunye ne-vivo genotoxicity kunye novavanyo lwe-pharmacological.Akukho tshintsho lwe-genotoxic okanye lwe-mutagenic lwabonwa kunye nolawulo lwe-Betadex Sulfobutyl Ether Sodium.I-Betadex Sulfobutyl Ether Sodium i-biocompatible kwaye ayibonisi umsebenzi we-pharmacological.Ikhutshwa ngokukhawuleza i-metabolized xa ilawulwa nge-intravenously.
I-Betadex Sulfobutyl Ether Sodium ifakwe kwi-IV kunye ne-IM yeemveliso ezitofwayo ngoku ezivunyiweyo kwaye zithengiswa e-USA, eYurophu naseJapan.Ifakwe kwi-FDA ye-Inactive Ingredients Database ye-IM kunye ne-IV yokusetyenziswa.Ukusetyenziswa kwayo ngezinye iindlela, kubandakanywa ne-SC, ngomlomo, i-inhalation, i-nasal kunye ne-ophthalmic, ivavanywa kwizifundo zeklinikhi.
Ukusebenzisa i-β-cyclodextrin kunye ne-1,4-sulfobutyrolactone njengezinto ezibonakalayo, ngokuzisa inani elifanelekileyo le-solvent ye-organic kwisisombululo se-alkaline yamanzi, i-solubility ye-1,4-sulfobutyrolactone iyanda, kunye nemveliso ye-synthesis ye-sulfobutyl ether-β-cyclodexin iphuculwe;isisombululo semveliso efunyenweyo sixhomekeke kwi-ultrasonic dialysis, i-carbon activated decolorization, i-freeze yokumisa kunye neminye imisebenzi yokufumana iimveliso ze-sulfobutyl ether-β-cyclodextrin powder.